Brazil's National Health Surveillance Agency (Anvisa) recorded a significant increase of 130% in adverse event notifications related to cosmetic products following the implementation of new regulations. This substantial growth reflects the direct impact of measures adopted to strengthen sanitary surveillance in the sector.
The new Anvisa regulations established more rigorous requirements for monitoring and reporting adverse events associated with cosmetic use. These regulatory changes aim to improve consumer safety and ensure that manufacturers and distributors comply with their pharmacovigilance obligations.
The increase in notifications can be interpreted in two complementary ways: it indicates both the strengthening of the surveillance system and greater compliance by companies with regulatory requirements. With clearer rules and better-defined obligations, manufacturers and distributors tend to report detected adverse events more frequently.
This scenario demonstrates the importance of maintaining robust sanitary surveillance systems. Anvisa continues to intensify actions to ensure that cosmetic products sold in Brazil meet the safety and quality standards required by law.
The agency emphasizes that consumers should report any adverse reactions when using cosmetics to the competent surveillance authorities. This active participation contributes to continuous monitoring of the safety of products available on the market and helps identify potential public health risks.
